• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker may bid for Smith & Nephew following 6-month no-bid period | The week in medtech M&A

Stryker may bid for Smith & Nephew following 6-month no-bid period | The week in medtech M&A

November 26, 2014 By MassDevice Contributors Network

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

Will Stryker bid on Smith & Nephew this week?

Stryker is free to make an offer for Smith & Nephew after a 6-month no-bid period elapsed last week, fueling speculation that the U.S orthopedics giant will move on its British rival.

Under British law Stryker was barred from bidding on Smith & Nephew after demurring in May. Read more

J&J demands $7.2 billion from Boston Scientific as trial begins

November 20, 2014 by MassDevice

J&J demands $7.2 billion from Boston Scientific as trial begins

Boston Scientific should pay Johnson & Johnson $7.23 billion in damages and interest for breach of contract, nearly 9 years after Boston Scientific won a controversial bidding war for device maker Guidant, lawyers for J&J told a U.S. federal judge today.

“To be blunt about it, Guidant cheated – and then it lied to Johnson & Johnson so Johnson & Johnson would not discover what Guidant had done,” attorney Harold Weinberger said at the start of a non-jury trial in Manhattan federal court. Read more

Will Orange County's medtech scene lose its juice without Allergan?

November 20, 2014 by Brian Johnson

Will Orange County's medtech scene lose its juice without Allergan?

Allergan has been around these parts since there were more orange groves in Orange County, Calif., than pink Rolls Royces.

For 60 years the medical aesthetics giant has called Orange County home, with Irvine serving as a centerpoint for the robust medical technology sector that has sprung up around it and become one of the top-performing medtech clusters in the world. Read more

BD-CareFusion deal passes US anti-trust waiting period

November 21, 2014 by Mark Hollmer

BD-CareFusion deal passes US anti-trust waiting period

Becton Dickinson’s $12.2 billion bid for device maker CareFusion cleared a big regulatory hurdle this week.

The New Jersey medical equipment maker disclosed that the required waiting period under U.S. antitrust regulations expired Nov. 19. Read more

Sources: Stryker weighs bid for Smith & Nephew

November 24, 2014 by MassDevice

Sources: Stryker weighs bid for Smith & Nephew

U.S. medical device maker Stryker is examining a bid for Britain’s Smith & Nephew as a regulatory restriction barring an offer comes to an end, Bloomberg reported today, citing unnamed sources.

Shares of Smith & Nephew, which makes artificial knees and hips, rose as much as 10%. Read more

Filed Under: Mergers & Acquisitions, News Well Tagged With: Actavis, Allergan, Alphaeon, becton dickinson, Boston Scientific, CareFusion Corp., Covidien, Guidant Corp., Johnson and Johnson, Masimo, Smith & Nephew, Stryker, Valeant Pharmaceuticals

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy